Who is sponsoring NCT05661071?

NCT05661071 is sponsored by Hacettepe University.

What drugs are being tested in NCT05661071?

Interventions in NCT05661071: Modified Mini Mental Test:, The Controlled Oral Word Association Test, The Central Nervous System Vital Signs, Conners' Parent Rating Scale-48 (Parent Report), Child Behavior Checklist 6-18 ages (Parent Report), Strengths and Difficulties Questionnaire (Self-Reported), Brooke Lower Extremity Functional Classification, Motor Function Measurement-32 Items, Four Square Step Test, Six Minutes Walk Test, Timed Performance Test.

What condition does NCT05661071 study?

NCT05661071 studies Duchenne Muscular Dystrophy.

Is NCT05661071 still recruiting?

NCT05661071 is currently status unknown. Last updated 22 December 2022.

Last reviewed 2022-12-22 · How we verify

NCT05661071

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions

Status unknown Last updated 22 December 2022

What this trial tests

trial testing Modified Mini Mental Test: in Duchenne Muscular Dystrophy in 74 participants. Status unknown.

Timeline

11 May 2022

Primary endpoint
1 March 2023

1 March 2023

Quick facts

Lead sponsor	Hacettepe University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	74
Start date	11 May 2022
Primary completion	1 March 2023
Estimated completion	1 March 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Modified Mini Mental Test:
The Controlled Oral Word Association Test
The Central Nervous System Vital Signs
Conners' Parent Rating Scale-48 (Parent Report)
Child Behavior Checklist 6-18 ages (Parent Report)
Strengths and Difficulties Questionnaire (Self-Reported)
Brooke Lower Extremity Functional Classification
Motor Function Measurement-32 Items
Four Square Step Test
Six Minutes Walk Test
Timed Performance Test

Conditions studied

Duchenne Muscular Dystrophy — all drugs for Duchenne Muscular Dystrophy →

Sponsor

Hacettepe University

Who can join

Adults 7 to 16, male only, with Duchenne Muscular Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to determine neuropsychological profiles of children with Duchenne Muscular Dystrophy and investigation of its effects on motor functions \& compare to typically developed peers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive and emotional-behavioural outcomes of Turkish Duchenne muscular dystrophy population and its association with motor function.
Aldırmaz E, Bulut N, Yılmaz Ö, Alemdaroğlu-Gürbüz İ. · · 2024 · PMID 39180809 · DOI 10.1016/j.ejpn.2024.08.004

Verify or expand the search:

Other recruiting trials for Duchenne Muscular Dystrophy

Currently open trials in the same condition.

NCT07287189 — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients · Phase 2 · recruiting
NCT06817382 — A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Ma · Phase 1 · recruiting
NCT06402942 — Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy · NA · recruiting
NCT06450639 — A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) · Phase 2 · active not recruiting
NCT06692426 — Trial of Cell Based Therapy for DMD · Phase 1 · recruiting

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05661071 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing